USPTO serial 97328722
ORIPATCH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 5, 2023
- Examiner
- BRUNDAGE, DAVID WILLIAM
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ORIPATCH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Kristiansand S, NO
Kristiansand S, NO
Kristiansand S, NO
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John R. Schaefer
John R. Schaefer Bacon & Thomas, PLLC201 N. Union Street, Suite 320Alexandria, VA 22314-2650United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Oral patches, oral plasters, oral films and oral tapes, for medical purposes; oral patches, oral plasters, oral films and oral tapes, for medical treatment; medicated oral patches, oral plasters, oral films and oral tapes; oral patches, oral plasters, oral films and oral tapes, for pain relief; adhesive oral patches, oral plasters, oral films and oral tapes, for medical purposes; dissolvable oral patches, oral plasters, oral films and oral tapes, for medical purposes; drug delivery agents in the form of oral patches, oral plasters, oral films and oral tapes, that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of oral patches, oral plasters, oral films and oral tapes, that facilitate the delivery of analgesics; drug delivery agents in the form of oral patches, oral plasters, oral films and oral tapes, that facilitate the delivery of anaesthetics; oral patches, oral plasters, oral films and oral tapes, for treating mouth ulcers; adhesive plasters for medical purposes; medicated adhesive plasters, patches, films, tapes and bands; adhesive patches, plasters, films, tapes and bands, for medical purposes; adhesive patches, plasters, films and tapes, for medical purposes for use on mucous membranes; adhesive plasters, patches, films, tapes and bands, for pain relief; drug delivery agents in the form of adhesive plasters, patches, films, tapes and bands, that facilitate the delivery of pharmaceuticals; drug delivery agents in the form of adhesive plasters, patches, films, tapes and bands, that facilitate the delivery of analgesics; drug delivery agents in the form of adhesive plasters, patches, films, tapes and bands, that facilitate the delivery of anaesthetics; sticking plasters for medical use; medical dressing; medical coverings, namely, bandages for dressings; medical applicators, namely, swabs for medical use; analgesics; anaesthetics; topical pharmaceuticals for the treatment of ulcers, lesions and infections and for pain relief; pharmaceutical preparations for the treatment of ulcers, lesions and infections and for pain relief; pharmaceutical preparations in the form of patches, plasters, films and tapes for the treatment of ulcers, lesions and infections and for pain relief; pharmaceutical preparations with analgesic properties; pharmaceutical preparations with anaesthetic properties; alginates for pharmaceutical purposes; drugs for medical purposes for the treatment of ulcers, lesions and infections and for pain relief; adhesives for dentures; replacement parts and fittings for all of the aforesaid goods | ACTIVE | — |
| 010 | Medical devices in the form of patches and implants for controlled release and administration of pharmaceuticals; pharmaceutical instruments, namely, patches and implants for controlled release and administration of pharmaceuticals; medical devices for the delivery of pharmaceuticals, namely, patches and implants for controlled release and administration of pharmaceuticals; medical devices in the form of patches and implants for the delivery of pharmaceuticals to intra-oral and extra-oral areas, mucous membranes, and skin; medical devices in the form of patches and implants for the delivery of analgesics; medical devices, namely, patches and implants for the delivery of analgesics to intra-oral and extra-oral areas, mucous membranes, and skin; medical devices, namely, patches and implants for the delivery of anaesthetics; medical devices, namely, patches and implants for the delivery of anaesthetics to intra-oral and extra-oral areas, mucous membranes, and skin; medical devices, namely, patches and implants for administering pain relief; medical devices, namely, patches and implants for administering pain relief to intra-oral and extra-oral areas, mucous membranes, and skin; replacement parts and fittings all of the aforesaid goods | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 2, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 2, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 2, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 2, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 2, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 5, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 5, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 30, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 5, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 5, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 5, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 5, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 19, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 19, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 19, 2023 | ALIE | ASSIGNED TO LIE | — |
| Mar 15, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 10, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 9, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 28, 2022 | NWAP | NEW APPLICATION ENTERED | — |